Sharon Bio-Medicine’s formulation unit at Silaqui, near Dehradun, Uttarakhand has received an approval from Canadian health authorities for supplying tablets and capsules to Canadian market. This approval would increase the sales and add more value to the margins of the company. Further, this formulation facility has already been GMP Certified by United Kingdom Medicines & Health Regulatory Authority.
Recently, Sharon Bio-Medicine had received Certification of Substances by European Directorate for the Quality of Medicines and Healthcare (EDQM) for one of its product namely -- Trimetazidine Dihydrochloride -- which is being manufactured at the company’s plant at Taloja near Navi Mumbai.
Sharon Bio-Medicine manufactures Active Pharma Ingredients (API), intermediate of API’s and formulations. The company is also having its own three R&D Units and one Toxicology Lab. Its three Units are located at MIDC, Taloja near Navi Mumbai and at Dehraddun, Uttarakhand.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: